These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

52 related items for PubMed ID: 1680435

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
    Akçiçek F, Ok E, Duman S, Kürsad S, Unsal A, Alev M, Atabay G, Basçi A.
    Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916
    [Abstract] [Full Text] [Related]

  • 3. The effect of change of renal replacement therapy on serum lipoprotein (a) concentration.
    Misra M, Webb AT, Reaveley DA, Doherty E, O'Donnell M, Seed M, Brown EA.
    Adv Perit Dial; 1997; 13():168-73. PubMed ID: 9360675
    [Abstract] [Full Text] [Related]

  • 4. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M, Delibasi T, Kaya A, Aydogan T, Koca C, Akcay A, Duranay M, Yigitoglu R.
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [Abstract] [Full Text] [Related]

  • 5. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K, Sasaki J, Arakawa K.
    Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
    [Abstract] [Full Text] [Related]

  • 6. Post-prandial effects of gemfibrozil vs simvastatin in hypercholesterolemic subjects with borderline hypertriglyceridemia.
    Vigna GB, Donega P, Passaro A, Zanca R, Cattin L, Fonda M, Pauciullo P, Marotta G, Fellin R, Gasparrini S, Piliego T.
    Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):234-43. PubMed ID: 10656170
    [Abstract] [Full Text] [Related]

  • 7. Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A.
    Superko HR, Berneis KK, Williams PT, Rizzo M, Wood PD.
    Am J Cardiol; 2005 Nov 01; 96(9):1266-72. PubMed ID: 16253595
    [Abstract] [Full Text] [Related]

  • 8. Effect of gemfibrozil on the composition and oxidation properties of very-low-density lipoprotein and high-density lipoprotein in patients with hypertriglyceridemia.
    Hsu HC, Lee YT, Yeh HT, Chen MF.
    J Lab Clin Med; 2001 Jun 01; 137(6):414-21. PubMed ID: 11385362
    [Abstract] [Full Text] [Related]

  • 9. Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteins.
    Lupien PJ, Brun D, Gagné C, Moorjani S, Bielman P, Julien P.
    Can J Cardiol; 1991 Jun 01; 7(1):27-33. PubMed ID: 2025787
    [Abstract] [Full Text] [Related]

  • 10. Gemfibrozil in dyslipidaemia.
    Kundu SC, Roxy S, Batabyal SK.
    J Assoc Physicians India; 1990 Feb 01; 38(2):156-9. PubMed ID: 2199426
    [Abstract] [Full Text] [Related]

  • 11. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
    Mackness MI, Bhatnagar D, Durrington PN, Prais H, Haynes B, Morgan J, Borthwick L.
    Eur J Clin Nutr; 1994 Dec 01; 48(12):859-65. PubMed ID: 7889894
    [Abstract] [Full Text] [Related]

  • 12. Gemfibrozil increases paraoxonase activity in type 2 diabetic patients. A new hypothesis of the beneficial action of fibrates?
    Balogh Z, Seres I, Harangi M, Kovács P, Kakuk G, Paragh G.
    Diabetes Metab; 2001 Nov 01; 27(5 Pt 1):604-10. PubMed ID: 11694861
    [Abstract] [Full Text] [Related]

  • 13. Gemfibrozil also corrects dyslipidemia in postmenopausal women and smokers.
    Koskinen P, Kovanen PT, Tuomilehto J, Manninen V.
    Arch Intern Med; 1992 Jan 01; 152(1):90-6. PubMed ID: 1728934
    [Abstract] [Full Text] [Related]

  • 14. [Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide].
    Berioli S, Bentivoglio M, Conti R, Osanna RA, Savino K, Zollino L, Corea L.
    Cardiologia; 1990 Apr 01; 35(4):335-40. PubMed ID: 2245435
    [Abstract] [Full Text] [Related]

  • 15. Reducing hypertriglyceridemia in elderly patients with cerebrovascular disease stabilizes or improves cognition and cerebral perfusion.
    Rogers RL, Meyer JS, McClintic K, Mortel KF.
    Angiology; 1989 Apr 01; 40(4 Pt 1):260-9. PubMed ID: 2705633
    [Abstract] [Full Text] [Related]

  • 16. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
    Jover E, Aranda JL, Nogués X, del Palacio A, Rubiés-Prat J.
    Med Clin (Barc); 1996 May 25; 106(20):776-9. PubMed ID: 8801396
    [Abstract] [Full Text] [Related]

  • 17. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW, Huff M, Oskalns R, Rudas L, Kostuk WJ.
    J Heart Lung Transplant; 1995 May 25; 14(4):613-22. PubMed ID: 7578166
    [Abstract] [Full Text] [Related]

  • 18. Lipid-lowering effects of lovastatin in CAPD patients.
    Jacobs RH, Lal SM, Nolph KD.
    Adv Perit Dial; 1993 May 25; 9():288-90. PubMed ID: 8105945
    [Abstract] [Full Text] [Related]

  • 19. [Therapy of hypercholesterolemia and hypertriglyceridemia. Comparison of hypolipemic effects of lovastatin and gemfibrozil].
    Gavelli MS, Vitaliano E, Rossi FG, Serra T, Santini G, Bernardi G.
    Clin Ter; 1991 Jan 15; 136(1):31-8. PubMed ID: 1826871
    [Abstract] [Full Text] [Related]

  • 20. Effect of gemfibrozil on change in renal function in men with moderate chronic renal insufficiency and coronary disease.
    Tonelli M, Collins D, Robins S, Bloomfield H, Curhan GC.
    Am J Kidney Dis; 2004 Nov 15; 44(5):832-9. PubMed ID: 15492949
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.